These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 28834167)

  • 1. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.
    Scheltema MJ; van den Bos W; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
    BJU Int; 2017 Nov; 120 Suppl 3():51-58. PubMed ID: 28834167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal irreversible electroporation as primary treatment for localized prostate cancer.
    van den Bos W; Scheltema MJ; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
    BJU Int; 2018 May; 121(5):716-724. PubMed ID: 28796935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer.
    Geboers B; Scheltema MJ; Blazevski A; Katelaris A; Doan P; Ali I; Agrawal S; Barreto D; Matthews J; Haynes AM; Delprado W; Shnier R; Thompson JE; Stricker PD
    BJU Int; 2023 Jun; 131 Suppl 4():14-22. PubMed ID: 36594205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.
    Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P
    Eur Urol Oncol; 2020 Jun; 3(3):283-290. PubMed ID: 31103721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE).
    Blazevski A; Amin A; Scheltema MJ; Balakrishnan A; Haynes AM; Barreto D; Cusick T; Thompson J; Stricker PD
    World J Urol; 2021 Apr; 39(4):1107-1114. PubMed ID: 32488359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage irreversible electroporation for radio-recurrent prostate cancer - the prospective FIRE trial.
    Blazevski A; Geboers B; Scheltema MJ; Gondoputro W; Doan P; Katelaris A; Agrawal S; Baretto D; Matthews J; Haynes AM; Delprado W; Shnier R; van den Bos W; Thompson JE; Lawrentschuk N; Stricker PD
    BJU Int; 2023 Jun; 131 Suppl 4():23-31. PubMed ID: 36495482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy.
    Scheltema MJ; Chang JI; Böhm M; van den Bos W; Blazevski A; Gielchinsky I; Kalsbeek AMF; van Leeuwen PJ; Nguyen TV; de Reijke TM; Siriwardana AR; Thompson JE; de la Rosette JJ; Stricker PD
    World J Urol; 2018 Sep; 36(9):1383-1389. PubMed ID: 29594551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer.
    van Riel LAMJG; Geboers B; Kabaktepe E; Blazevski A; Reesink DJ; Stijns P; Stricker PD; Casanova J; Dominguez-Escrig JL; de Reijke TM; Scheltema MJ; Oddens JR
    BJU Int; 2022 Nov; 130(5):611-618. PubMed ID: 35474600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.
    Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ
    BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control.
    Ting F; Tran M; Böhm M; Siriwardana A; Van Leeuwen PJ; Haynes AM; Delprado W; Shnier R; Stricker PD
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):46-52. PubMed ID: 26458959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes.
    Blazevski A; Gondoputro W; Scheltema MJ; Amin A; Geboers B; Barreto D; Haynes AM; Shnier R; Delprado W; Agrawal S; Thompson JE; Stricker PD
    BMC Urol; 2022 Mar; 22(1):28. PubMed ID: 35236338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy.
    de Castro Abreu AL; Bahn D; Leslie S; Shoji S; Silverman P; Desai MM; Gill IS; Ukimura O
    BJU Int; 2013 Aug; 112(3):298-307. PubMed ID: 23826840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer.
    Scheltema MJ; Geboers B; Blazevski A; Doan P; Katelaris A; Agrawal S; Barreto D; Shnier R; Delprado W; Thompson JE; Stricker PD
    BJU Int; 2023 Jun; 131 Suppl 4():6-13. PubMed ID: 36495481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact on genitourinary function and quality of life following focal irreversible electroporation of different prostate segments.
    Scheltema MJ; Chang JI; van den Bos W; Gielchinsky I; Nguyen TV; Reijke TM; Siriwardana AR; Böhm M; de la Rosette JJ; Stricker PD
    Diagn Interv Radiol; 2018 Sep; 24(5):268-275. PubMed ID: 30211680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer.
    Kanthabalan A; Peters M; Van Vulpen M; McCartan N; Hindley RG; Emara A; Moore CM; Arya M; Emberton M; Ahmed HU
    BJU Int; 2017 Aug; 120(2):246-256. PubMed ID: 28258616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.
    Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B
    Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes.
    Collettini F; Enders J; Stephan C; Fischer T; Baur ADJ; Penzkofer T; Busch J; Hamm B; Gebauer B
    Radiology; 2019 Jul; 292(1):250-257. PubMed ID: 31161973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study.
    Yaxley WJ; Gianduzzo T; Kua B; Oxford R; Yaxley JW
    Investig Clin Urol; 2022 May; 63(3):285-293. PubMed ID: 35534217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer.
    Hsu CC; Hsu H; Pickett B; Crehange G; Hsu IC; Dea R; Weinberg V; Gottschalk AR; Kurhanewicz J; Shinohara K; Roach M
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):370-7. PubMed ID: 22672747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
    Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
    BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.